Innovative Carbon Dots-Based Therapy Offers New Hope Against Drug-Resistant Lung Cancer
Editor: Tiffany Researchers have developed a carbon dots-based nanozyme that co-delivers doxorubicin and siRNA to effectively address drug-resistant lung cancer, potentially enhancing treatment options for affected patients. Key Highlights Context…
Breakthrough in Nanoparticle-Based Drug Delivery: A New Hope for Lung Cancer and COPD Treatment
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) remain among the leading causes of mortality worldwide, driven by factors such as smoking-induced inflammation, oxidative stress, and tissue remodeling. Despite…